-
The US has suspended most funding for South Africa's HIV programs, impacting thousands of health workers and clinics. Despite a new bridge plan, tensions remain high amid strained diplomatic relations and ongoing political disputes. The move threatens progress in HIV prevention and treatment in the region.
-
African nations are making strides in vaccine development and manufacturing. South Africa begins clinical trials for a locally produced cholera vaccine, aiming for approval by 2028. Meanwhile, Nigeria progresses with a Lassa fever vaccine, addressing regional health needs and reducing dependency on imports.
-
The upcoming G20 summit in Johannesburg is impacted by the US and China boycotts. The US is withdrawing over South Africa's stance on racial policies, while China is reducing travel. South Africa aims to highlight global issues like climate change, debt, and inequality despite these absences.